Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Clinical Research and Equipment Industry Analysis

UpdatedApr 30, 2026
DataAggregated Company Financials
Companies11
  • 7D12.3%
  • 3M21.9%
  • 1Y23.7%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 7.9%, with Locus Cell up 36%. This takes the industry's 12 month performance to a gain of 18%.

Industry Valuation and Performance

Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 30 Apr 2026NT$41.8bNT$2.5b-NT$764,028,000.0021.8x-54.7x16.6x
Sat, 28 Mar 2026NT$31.5bNT$2.5b-NT$747,966,000.0020.6x-42.1x12.6x
Mon, 23 Feb 2026NT$33.3bNT$2.4b-NT$689,929,000.0023.8x-48.3x13.7x
Wed, 21 Jan 2026NT$34.6bNT$2.4b-NT$689,929,000.0024.7x-50.2x14.2x
Fri, 19 Dec 2025NT$34.5bNT$2.4b-NT$670,921,000.0022.8x-51.5x14.1x
Sun, 16 Nov 2025NT$40.2bNT$2.5b-NT$679,280,000.0019.4x-59.2x16.4x
Tue, 14 Oct 2025NT$38.3bNT$2.5b-NT$870,437,000.0019.1x-44x15.6x
Thu, 11 Sep 2025NT$35.5bNT$2.5b-NT$819,216,000.0019.7x-43.3x14.5x
Sat, 09 Aug 2025NT$33.2bNT$2.5b-NT$600,003,000.0020.6x-55.4x13.5x
Mon, 07 Jul 2025NT$33.5bNT$2.5b-NT$600,003,000.0023.1x-55.8x13.6x
Wed, 04 Jun 2025NT$33.3bNT$2.5b-NT$600,003,000.0022.2x-55.4x13.5x
Fri, 02 May 2025NT$32.0bNT$2.5b-NT$540,128,000.0024x-59.2x13x
Sun, 30 Mar 2025NT$36.1bNT$2.4b-NT$560,979,000.0028.9x-64.4x15x
Tue, 25 Feb 2025NT$37.5bNT$2.6b-NT$854,432,000.0024.1x-43.9x14.6x
Thu, 23 Jan 2025NT$36.8bNT$2.6b-NT$854,432,000.0023.5x-43.1x14.4x
Sat, 21 Dec 2024NT$34.3bNT$2.6b-NT$854,432,000.0024.5x-40.2x13.4x
Mon, 18 Nov 2024NT$40.7bNT$2.5b-NT$856,799,000.0024x-47.5x16x
Wed, 16 Oct 2024NT$40.7bNT$2.3b-NT$836,610,000.0022.3x-48.6x17.9x
Fri, 13 Sep 2024NT$40.3bNT$2.3b-NT$836,610,000.0021.5x-48.2x17.7x
Sun, 11 Aug 2024NT$39.3bNT$2.1b-NT$791,513,000.0027.9x-49.7x18.5x
Tue, 09 Jul 2024NT$45.2bNT$2.1b-NT$797,765,000.0034.4x-56.7x21.2x
Thu, 06 Jun 2024NT$41.2bNT$2.1b-NT$797,765,000.0033.7x-51.7x19.3x
Sat, 04 May 2024NT$39.8bNT$2.1b-NT$914,899,000.0032.4x-43.5x18.8x
Mon, 01 Apr 2024NT$40.3bNT$2.1b-NT$903,875,000.0031.7x-44.6x19.1x
Wed, 28 Feb 2024NT$44.0bNT$2.1b-NT$610,218,000.0033.5x-72x21.2x
Fri, 26 Jan 2024NT$44.5bNT$2.1b-NT$610,218,000.0033.2x-72.9x21.4x
Sun, 24 Dec 2023NT$47.2bNT$2.1b-NT$610,218,000.0033.5x-77.3x22.7x
Tue, 21 Nov 2023NT$47.5bNT$2.1b-NT$609,632,000.0030.9x-77.9x22.9x
Thu, 19 Oct 2023NT$46.1bNT$2.2b-NT$497,769,000.0030.8x-92.7x20.7x
Sat, 16 Sep 2023NT$43.6bNT$2.2b-NT$497,769,000.0031x-87.5x19.6x
Mon, 14 Aug 2023NT$43.9bNT$2.2b-NT$491,561,000.0042.6x-89.4x19.6x
Wed, 12 Jul 2023NT$47.9bNT$2.5b-NT$274,767,000.0042.8x-174.5x19.6x
Fri, 09 Jun 2023NT$49.2bNT$2.5b-NT$274,767,000.0042.5x-178.9x20.1x
Sun, 07 May 2023NT$53.0bNT$2.7b-NT$29,017,000.0024.4x-1826.6x19.9x
Price to Earnings Ratio

-1826.6x


Total Market Cap: NT$53.0bTotal Earnings: -NT$29,017,000.00Total Revenue: NT$2.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Clinical Research and Equipment Industry Price to Earnings3Y Average -101x202420252026
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 17.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Taiwanese Clinical Research and Equipment compare with similar industries?

TW Market3.03%
Healthcare-1.87%
Life Sciences12.34%
Clinical Research and Equipment12.34%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6891 Locus CellNT$78.5030.4%
+NT$3.7b		256.8%PS1232.8x
7837 Creative Life ScienceNT$111.505.2%
+NT$123.0m		n/an/a
7607 DuoGenic StemCellsNT$15.358.5%
+NT$36.7m		5.1%n/a

Latest News

6848
NT$18.80
RBC Bioscience
7D
-4.1%
1Y
14.6%
6891
NT$78.50
Locus Cell
7D
30.4%
1Y
256.8%
6939
NT$23.45
TFBS Bioscience
7D
-8.9%
1Y
-7.7%
6986
NT$62.00
HeXun Biosciences
7D
-3.9%
1Y
-19.2%
7607
NT$15.35
DuoGenic StemCells
7D
8.5%
1Y
5.1%
6662
NT$29.10
BioLASCO Taiwan
7D
-1.9%
1Y
-12.7%
7837
NT$111.50
Creative Life Science
7D
5.2%
1Y
n/a
6589
NT$45.25
EirGenix
7D
-3.7%
1Y
-28.7%
6661
NT$18.00
Welgene BiotechLtd
7D
-3.0%
1Y
-12.4%
4133
NT$21.60
Abnova (Taiwan)
7D
-3.4%
1Y
-24.7%